Skip to content
10-Q

Quarterly Report

CHELSEA THERAPEUTICS INTERNATIONAL, LTD.

0001144204-13-058837

← back to feed
Filed
Nov 5, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 5, 2013 70.77M sh
Capex Q3 2013 · Sep 30, 2013 $0
Capex Q3 2013 · Sep 30, 2013 $739.73K
Capex Q3 2013 · Sep 30, 2012 $25.26K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$10.47M
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$210.43M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$34.73M
Cash And Equivalents Q3 2013 · Sep 30, 2013 $20.88M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $28.42M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $33.04M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $41.11M
Cash And Equivalents Q3 2013 · Apr 2, 2002 $0
Stockholders Equity Q3 2013 · Sep 30, 2013 $19.19M
Stockholders Equity Q3 2013 · Dec 31, 2012 $25.92M
Total Liabilities Q3 2013 · Sep 30, 2013 $2.95M
Total Liabilities Q3 2013 · Dec 31, 2012 $3.01M
Current Assets Q3 2013 · Sep 30, 2013 $22.08M
Current Assets Q3 2013 · Dec 31, 2012 $28.78M
Total Assets Q3 2013 · Sep 30, 2013 $22.15M
Total Assets Q3 2013 · Dec 31, 2012 $28.93M
Sga Expense Q3 2013 · Sep 30, 2013 $1.05M
Sga Expense Q3 2013 · Sep 30, 2013 $3.85M
Sga Expense Q3 2013 · Sep 30, 2013 $34.75M
Sga Expense Q3 2013 · Sep 30, 2012 $1.17M
Sga Expense Q3 2013 · Sep 30, 2012 $4.53M
Rd Expense Q3 2013 · Sep 30, 2013 $2.56M
Rd Expense Q3 2013 · Sep 30, 2013 $6.42M
Rd Expense Q3 2013 · Sep 30, 2013 $168.93M
Rd Expense Q3 2013 · Sep 30, 2012 $2.48M
Rd Expense Q3 2013 · Sep 30, 2012 $15.87M
Net Income Q3 2013 · Sep 30, 2013 −$3.84M
Net Income Q3 2013 · Sep 30, 2013 −$11.1M
Net Income Q3 2013 · Sep 30, 2013 −$226.16M
Net Income Q3 2013 · Sep 30, 2012 −$6.08M
Net Income Q3 2013 · Sep 30, 2012 −$29.51M
Operating Income Q3 2013 · Sep 30, 2013 −$3.85M
Operating Income Q3 2013 · Sep 30, 2013 −$11.11M
Operating Income Q3 2013 · Sep 30, 2013 −$230.92M
Operating Income Q3 2013 · Sep 30, 2012 −$6.09M
Operating Income Q3 2013 · Sep 30, 2012 −$29.57M